Comparison of lymphocyte differentiation and activation across cancer types revealed cancer-dependent differences for some subsets (e.g., CD25+ T cells, CD137+ T cells or memory B cells), while others showed less variety (e.g., CD69 or effector memory T cells) (Fig. 1d–f and Supplementary Fig. 3a–e). Here, TNFRSF9 is linked to cancer.